The Pharmaletter

One To Watch

i-mab-biopharma-company-logo

I-Mab Biopharma

A global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies and biologics for oncology.

I-Mab’s innovative pipeline is driven by internal R&D’s Fast-to-Proof-of-Concept, Fast-to-Market development strategies, and through global partnerships. Founded in 2016, the company has offices in the USA and China.

Want to Update your Company's Profile?


More I-Mab Biopharma news >